Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Molecular Features of Primary Central Nervous System Lymphoma in a Large Tissue Microarray

Diego Villa, MD, Graham W Slack, MD PhD, Muntadhar Al-Moosawi, MD, Susana Ben-Neriah, BSc, Tamara Shenkier, MD, Joseph M. Connors, MD, Laurie H Sehn, MDMPH, Kerry J Savage, BSc, MD MSc, David W. Scott, PhDMD,FRACP,FRCPA, Christian Steidl, MD, Randy D. Gascoyne, MD, King Tan, MD

Blood (2018) 132 (Supplement 1): 348.

https://doi.org/10.1182/blood-2018-99-114218

Published: 2018

Journal Articles

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Laurie H Sehn, MD MPH, Edward L G Hardy, MD FRCPC, Karamjit K Gill, MD FRCPC, Abdulwahab J Al-Tourah, MBChB, FRCPC, Jesse Shustik, MD, Nicol A Macpherson, MDPhDFRCPC,, Adrian Yee, MD FRCPC, Wendy Lam, MD, Kerry J. Savage, MD MSc, Richard Klasa, MD CM, FRCP(C), Diego Villa, MDMPH, Alina S Gerrie, MD, Tamara Shenkier, MD, Graham W Slack, MD, Randy D. Gascoyne, MD, Francois Benard, MD, Don Wilson, MD, Peter Tonseth, MD, Joseph M Connors, MD

Blood (2014) 124 (21): 392.

https://doi.org/10.1182/blood.V124.21.392.392

Published: 2014

Journal Articles

Outcome in Unselected Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Following R-CHOP When Stem Cell Transplantation Is Not Feasible

Roopesh R. Kansara, MD, Kerry J. Savage, MD MSc, Diego Villa, MDMPH, Tamara Shenkier, MD, Alina S. Gerrie, MD MPH, Richard Klasa, MD, Felicitas Hitz, MD, David W. Scott, MBChB, PhD, Graham W. Slack, MD, Randy D. Gascoyne, MD, Joseph M Connors, MD, Laurie H. Sehn, MDMPH

Blood (2014) 124 (21): 3069.

https://doi.org/10.1182/blood.V124.21.3069.3069

Published: 2014

Journal Articles

Rituximab with High Dose Methotrexate in the Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Roopesh R. Kansara, MD, Tamara Shenkier, MD, Joseph M Connors, MD, Alina S. Gerrie, MD MPH, Richard Klasa, MD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MD MPH, Diego Villa, MDMPH

Blood (2014) 124 (21): 3090.

https://doi.org/10.1182/blood.V124.21.3090.3090

Published: 2014

Journal Articles

Gemcitabine, Dexamethasone, and Cisplatin (GDP) As Secondary Chemotherapy In Relapsed/Refractory Peripheral T-Cell Lymphoma

Stephen Parkin, MD, BSc, Joseph M. Connors, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Richard Klasa, MD, Alina S. Gerrie, MD, Randy D. Gascoyne, MD, Tamara Shenkier, MD, Cynthia L. Toze, MD, John D. Shepherd, MD, Kevin Song, MD, Kerry J. Savage, MD, MSc

Blood (2013) 122 (21): 4345.

https://doi.org/10.1182/blood.V122.21.4345.4345

Published: 2013

Journal Articles

The Use Of GDP (Gemcitabine, Dexamethasone and Cisplatin) in The Primary Therapy Of Peripheral T-Cell Lymphomas

Jean-Michel Lavoie, MD, CM, MEng, Joseph M. Connors, MD, Diego Villa, MD, MPH, Richard Klasa, MD, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Alina S. Gerrie, MD, Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, MSc

Blood (2013) 122 (21): 1804.

https://doi.org/10.1182/blood.V122.21.1804.1804

Published: 2013

Journal Articles

The Outcome Of Patients With Post Transplant and Immunodeficiency Associated Lymphoproliferative Disorder: The BCCA Experience

Amrit Kahlon, MD, Graham W. Slack, MD, Yuhua Sun, MD, Richard Klasa, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Kerry J. Savage, MD, MSc

Blood (2013) 122 (21): 4390.

https://doi.org/10.1182/blood.V122.21.4390.4390

Published: 2013

Journal Articles

Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)

Katharine He Xing, MD, Amrit Kahlon, MD, Joseph M. Connors, MD, Brian Skinnider, MD, Randy D. Gascoyne, MD, Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, MSc, Graham W. Slack, MD, Tamara Shenkier, MD, Richard Klasa, MD, Alina S. Gerrie, MD, Diego Villa, MD, MPH

Blood (2013) 122 (21): 4369.

https://doi.org/10.1182/blood.V122.21.4369.4369

Published: 2013

Journal Articles

Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma

Edward G. Brooks, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Randy D. Gascoyne, MD, Kerry J. Savage, MD, MSc, Tamara Shenkier, MD, Richard Klasa, MD, Alina S. Gerrie, MD, Brian Skinnider, MD, Graham Slack, MD, Diego Villa, MD, MPH

Blood (2013) 122 (21): 4237.

https://doi.org/10.1182/blood.V122.21.4237.4237

Published: 2013

Journal Articles

The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era

Kerry J. Savage, MD, MSc, Paul R. Yenson, MD, BSc, FRCPC, Tamara Shenkier, MD, Richard Klasa, MD, Diego Villa, MD, MPH, Ozge Goktepe, MSc, Christian Steidl, MD, Graham W. Slack, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD

Blood (2012) 120 (21): 303.

https://doi.org/10.1182/blood.V120.21.303.303

Published: 2012

Journal Articles

Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era

Wendie-lou D. den Brok, MD, Kevin W. Song, MD, FRCPC, Hilary M. OLeary, MD, Richard Klasa, MD, Kerry J. Savage, MD MSc, Tamara Shenkier, MD, Diego Villa, MD, MPH, Graham W. Slack, MD, John D. Shepherd, MD, FRCPC, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD

Blood (2012) 120 (21): 1602.

https://doi.org/10.1182/blood.V120.21.1602.1602

Published: 2012

Journal Articles

Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors

Vivien Mak, MBBS FHKAM, Joseph M. Connors, MD, Richard Klasa, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Tamara Shenkier, MD, Mukesh Chhanabhai, MD, Randy D. Gascoyne, MD, Kerry J. Savage, MD MSc

Blood (2011) 118 (21): 96.

https://doi.org/10.1182/blood.V118.21.96.96

Published: 2011

Journal Articles

Diffuse Large B-Cell Lymphoma with Testicular Involvement: Outcome and Risk of CNS Relapse in the Rituximab Era

David Telio, MD, Diego Villa, MD, MPH, Tamara Shenkier, MD, Laurie H. Sehn, MD, MPH, Richard Klasa, MD, CM, King Tan, MBBS, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Kerry J. Savage, MD MSc

Blood (2011) 118 (21): 780.

https://doi.org/10.1182/blood.V118.21.780.780

Published: 2011

Journal Articles

FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP

Laurie H. Sehn, MD, MPH, Paul Hoskins, MD, Richard Klasa, MD, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Francois Benard, MD, Don Wilson, MD, James Morris, MD, Tom Pickles, MD, Joseph M. Connors, MD, Kerry J. Savage, MD

Blood (2010) 116 (21): 854.

https://doi.org/10.1182/blood.V116.21.854.854

Published: 2010

Journal Articles

Hodgkin Lymphoma Patients with Stage II B or Stage II Bulky Disease Have Advanced Disease and Should Not Be Included In Limited Stage Trials

Joseph M. Connors, MD, Randy D. Gascoyne, MD, Paul Hoskins, MD, James Morris, MD, Tom Pickles, MD, FRCPC, Laurie Sehn, MD, MPH, Tamara Shenkier, MD, Richard Klasa, MD, CM, FRCP(C), Nicholas Voss, MD, Kerry Joanne Savage, MD, BSc, MSc

Blood (2010) 116 (21): 417.

https://doi.org/10.1182/blood.V116.21.417.417

Published: 2010

Journal Articles

FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.

Kerry J. Savage, MD, MSc, Joseph M. Connors, MD, Don Wilson, MD, Richard Klasa, MD, Tamara Shenkier, MD, Paul Hoskins, MD, Nicholas Voss, MD, Laurie H. Sehn, MD

Blood (2007) 110 (11): 213.

https://doi.org/10.1182/blood.V110.11.213.213

Published: 2007

Journal Articles

Prognostic Utility of Extranodal Disease Involvement in Diffuse Large B-Cell Lymphoma in Patients Treated with R-CHOP.

David Hui, MD, MSc, Jane Donaldson, Paul Hoskins, MD, Richard Klasa, MD, Kerry J. Savage, MD, MPH, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Laurie Sehn, MD, MPH

Blood (2007) 110 (11): 1563.

https://doi.org/10.1182/blood.V110.11.1563.1563

Published: 2007

Journal Articles

Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Patients with a Negative Pet Scan Following Three Cycles of R-CHOP Can Be Effectively Treated with Abbreviated Chemoimmunotherapy Alone.

Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, Paul Hoskins, MD, Richard Klasa, MD, Tamara Shenkier, MD, Nicholas Voss, MD, Don Wilson, MD, Joseph M. Connors, MD

Blood (2007) 110 (11): 787.

https://doi.org/10.1182/blood.V110.11.787.787

Published: 2007

Journal Articles

Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry J. Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2006) 108 (11): 2739.

https://doi.org/10.1182/blood.V108.11.2739.2739

Published: 2006

Journal Articles

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Catherine Fitzgerald, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Kenneth Wilson, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2005) 106 (11): 492.

https://doi.org/10.1182/blood.V106.11.492.492

Published: 2005

NARROW

Molecular Features of Primary Central Nervous System Lymphoma in a Large Tissue Microarray

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Outcome in Unselected Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Following R-CHOP When Stem Cell Transplantation Is Not Feasible

Rituximab with High Dose Methotrexate in the Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Gemcitabine, Dexamethasone, and Cisplatin (GDP) As Secondary Chemotherapy In Relapsed/Refractory Peripheral T-Cell Lymphoma

The Use Of GDP (Gemcitabine, Dexamethasone and Cisplatin) in The Primary Therapy Of Peripheral T-Cell Lymphomas

The Outcome Of Patients With Post Transplant and Immunodeficiency Associated Lymphoproliferative Disorder: The BCCA Experience

Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)

Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma

The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era

Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era

Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors

Diffuse Large B-Cell Lymphoma with Testicular Involvement: Outcome and Risk of CNS Relapse in the Rituximab Era

FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP

Hodgkin Lymphoma Patients with Stage II B or Stage II Bulky Disease Have Advanced Disease and Should Not Be Included In Limited Stage Trials

FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.

Prognostic Utility of Extranodal Disease Involvement in Diffuse Large B-Cell Lymphoma in Patients Treated with R-CHOP.

Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Patients with a Negative Pet Scan Following Three Cycles of R-CHOP Can Be Effectively Treated with Abbreviated Chemoimmunotherapy Alone.

Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only